Gemcitabine and Irinotecan in Treating Patients With Metastatic Kidney Cancer

NCT00401128 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Kidney Cancer

Interventions

DRUG: gemcitabine hydrochloride
DRUG: irinotecan hydrochloride

Sponsor

The Cleveland Clinic

Collaborators

[object Object]